A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure
Clinical trial NCT06142383 · TERMINATED
Trial details
- NCT number
- NCT06142383
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2024-11-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.